| Patents for C07C 233 - Carboxylic acid amides (28,881) |
|---|
| 02/18/2010 | WO2009106552A3 Contrast agents |
| 02/18/2010 | US20100041905 Process for the Preparation of Substituted 2-Acetylamino-Alkoxyphenyl |
| 02/18/2010 | US20100041893 Formation of tetra-substituted enamides and stereoselective reduction thereof |
| 02/18/2010 | US20100041764 Therapeutic agent for diabetic neuropathy |
| 02/18/2010 | US20100041763 Salicylamide derivatives as nicotinic alpha 7 modulators |
| 02/18/2010 | US20100041762 Substituted fused-ring compounds for inflammation and immune-related uses |
| 02/18/2010 | US20100041717 N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases |
| 02/18/2010 | US20100041715 Sphingosine-1-phosphate (s1p) receptor antagonists and methods for use thereof |
| 02/18/2010 | US20100041657 Haloalkylsulfone substituted compounds useful for treating obesity and diabetes |
| 02/18/2010 | US20100041656 Novel amide derivatives and medicinal use thereof |
| 02/18/2010 | US20100040569 Photo-labile pro-fragrance conjugates |
| 02/18/2010 | CA2733970A1 Sphingosine-1-phosphate (s1p) receptor antagonists and methods for use thereof |
| 02/18/2010 | CA2731967A1 Synthesis of cyclohexane derivatives useful as sensates in consumer products |
| 02/17/2010 | EP1347950B1 Derivatives of 4-hydroxybutanoic acid and of its higher homologue as ligands of gamma-hydroxybutyrate (ghb) receptors, pharmaceutical compositions containing same and pharmaceutical uses |
| 02/17/2010 | CN101648885A Amide dimer and preparation method thereof |
| 02/16/2010 | USRE41135 Inhibitors of the 11-β-hydroxysteroid dehydrogenase type 1 enzyme |
| 02/16/2010 | US7663000 Quinoneimines of malonic acid diamides |
| 02/16/2010 | US7662999 treating gram negative bacterial infection or sepsis by neutralizing lipopolysaccharides |
| 02/16/2010 | US7662995 1-(2-Fluoro-4'-trifluoromethylbiphenyl-4-yl)cyclopropanecarboxylic acid, for example; treatment and/or prevention of Alzheimer's disease; inhibiting the release of A beta 42 peptide thereby being able to modulate gamma-secretase activity without affecting other important metabolic processes |
| 02/16/2010 | US7662994 Method for the preparation of crystalline dexloxiglumide and products obtained |
| 02/16/2010 | US7662839 EP receptor (for which the endogenous ligand is prostaglandin E2, PGE2); dysmenorrhoea, preterm labour, glaucoma, immune disorders, inflammatory disorders; e.g. {4-[(5-Phenyl-furan-2-carbonyl)-amino]-phenyl}-acetic acid |
| 02/16/2010 | CA2478183C Substituted amides |
| 02/16/2010 | CA2385081C Carboxylic acid compound and a medicament comprising it |
| 02/11/2010 | WO2010017563A1 Polymeric ionic liquids, methods of making and methods of use thereof |
| 02/11/2010 | WO2010015747A1 Novel process for obtaining the crystalline form v of agomelatine |
| 02/11/2010 | WO2010015746A1 Novel method for the synthesis of agomelatine |
| 02/11/2010 | WO2010015745A1 Novel method for the synthesis of agomelatine |
| 02/11/2010 | WO2010015744A1 Novel process for the synthesis of agomelatine |
| 02/11/2010 | WO2010015655A1 Cyclohexyl amide derivatives and their use as crf-1 receptor antagonists |
| 02/11/2010 | WO2010015415A1 Process for manufacturing adamantane derivatives with high yield |
| 02/11/2010 | US20100036165 Process for obtaining the crystalline form V of agomelatine |
| 02/11/2010 | US20100036163 Process for the synthesis of agomelatine |
| 02/11/2010 | US20100036153 Method for Producing Substituted Diamantanes |
| 02/11/2010 | US20100035999 Additives and products includings oligoesters |
| 02/11/2010 | CA2732887A1 Cyclohexyl amide derivatives and their use as crf-1 receptor antagonists |
| 02/10/2010 | EP2151430A1 New method for obtaining the crystalline form V of agomelatine |
| 02/10/2010 | EP2151429A1 Process for the preparation of agomelatin |
| 02/10/2010 | EP2151428A1 Process for the preparation of agomelatin |
| 02/10/2010 | EP2151427A1 New method for synthesising agomelatine |
| 02/10/2010 | EP2150525A1 Naphthyl(ethyl) acetamides |
| 02/10/2010 | CN101646646A Novel bis(dialkylamide) compounds, process for the preparation thereof and uses thereof |
| 02/10/2010 | CN101643434A New process for the synthesis of agomelatine |
| 02/10/2010 | CN101643433A New process for the synthesis of agomelatine |
| 02/10/2010 | CN101643432A New process for obtaining the crystalline form v of agomelatine |
| 02/10/2010 | CN101643431A New process for synthesizing agomelatine |
| 02/09/2010 | US7659428 Methods for producing acylphenylalanine |
| 02/09/2010 | US7659351 Water- and oil-repellent fluoroacrylates |
| 02/09/2010 | CA2484954C 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as vla-4 inhibitors |
| 02/09/2010 | CA2438704C Substituted propane-1,3-diamine derivatives and the pharmaceutical use thereof |
| 02/09/2010 | CA2430273C Ortho, meta-substituted bisaryl compounds, processes for their preparation, their use as medicament, and pharmaceutical preparations comprising them |
| 02/09/2010 | CA2410647C Substituted phenylpropanoic acid derivatives |
| 02/09/2010 | CA2294276C Branched chain fatty acids, their derivatives and use in the treatment of central nervous system disorders |
| 02/09/2010 | CA2294274C Compositions and methods for reversibly increasing permeability of biomembranes |
| 02/09/2010 | CA2201863C Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives as matrix metalloprotease inhibitors |
| 02/04/2010 | WO2010014209A2 Novel fullerene cyclopropanation reaction |
| 02/04/2010 | WO2010014179A1 Photolabile caged transition metal complexes and methods of using the same |
| 02/04/2010 | WO2010014022A1 A process for the preparation of imatinib |
| 02/04/2010 | WO2009129267A3 Small molecule inhibitors of the pleckstrin homology domain and methods for using same |
| 02/04/2010 | US20100029973 Fatty acid analogues for equilibrating bone mineral density |
| 02/04/2010 | US20100029767 Anthranilic acid derivatives |
| 02/04/2010 | US20100029726 Cyclohexanesulfonyl derivatives as glyt1 inhibitors to treat schizophrenia |
| 02/04/2010 | US20100029705 Administering an aminoindanyl derivative and; a steroid, dopamine receptor agonist or an anticholinergic or antimuscarinic agent; respiratory system disorders, antiallergens, chronic obstructive pulmonary disease, adult respiratory distress syndrome, bronchitis |
| 02/04/2010 | US20100029612 2-Aminoethyl Substituted Pyrimidin-2-Ones Cyclopropanes, Pyrazolines, Pyrimidines and Benzothiazepines and Their Uses as Urotensin II and Somatostatin 5 Receptor Ligands |
| 02/02/2010 | CA2555777C Dehydrating condensation agent having property of accumulating at interface with water |
| 01/28/2010 | WO2010011714A2 Reactive liquid modifiers |
| 01/28/2010 | WO2010011570A1 Adamantyl diamide derivatives and uses of same |
| 01/28/2010 | WO2010010174A1 1,1'-diadamantyl carboxylic acids, medicaments containing such compounds and their use |
| 01/28/2010 | WO2010009508A1 Antiparasitic compounds |
| 01/28/2010 | WO2009132452A8 Diaryl-cyclylalkyl derivatives as calcium channel blockers |
| 01/28/2010 | US20100022780 Process for preparing 2-amino-5-cyanobenzoic acid derivatives |
| 01/28/2010 | US20100022643 Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers |
| 01/28/2010 | US20100022597 2-adamantyl-butyramide derivatives as selective 11beta-hsd1 inhibitors |
| 01/28/2010 | US20100022547 Compounds and Methods for Treating Mammalian Gastrointestinal Parasitic Infections |
| 01/28/2010 | US20100022546 Adamantyl diamide derivatives and uses of same |
| 01/28/2010 | CA2734991A1 Activation of histone deacetylase 1 (hdac1) protects against dna damage and increases neuronal survival |
| 01/28/2010 | CA2730208A1 1,1'-diadamantyl carboxylic acids, medicaments containing such compounds and their use |
| 01/28/2010 | CA2728629A1 Adamantyl diamide derivatives and uses of same |
| 01/27/2010 | EP2146952A1 N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase |
| 01/27/2010 | EP1303503B1 Aniline derivatives |
| 01/27/2010 | CN101636378A Malonamides as orexin antagonists |
| 01/27/2010 | CN101633627A Process for producing 3-(N,N-diallyl)amino-4-p-methoxyacetanilide |
| 01/27/2010 | CN100584822C Preparation of acrylic acid derivatives from alpha or beta-hydroxy carboxylic acids |
| 01/27/2010 | CN100584816C Kutkin derivative, preparation method and application thereof |
| 01/27/2010 | CN100584460C Catalyst for asymmetric (transfer) hydrogenation |
| 01/26/2010 | US7652020 novel hydantoin derivatives to inhibit matrix metalloproteinases (MMPs), a disintegrin and metalloproteases (ADAMs) and/or tumor necrosis factor alpha converting enzyme (TACE) and in so doing prevent the release of tumor necrosis factor alpha (TNF- alpha ); autoimmune diseases; side effect reduction |
| 01/26/2010 | CA2310324C Method for preparing bromomethyl-biphenyl derivatives |
| 01/21/2010 | WO2010009068A2 Cyclohexenyl modulators of chemokine receptor activity |
| 01/21/2010 | WO2010007202A1 Enzymatic synthesis of enantiomerically enriched derivatives of cis- and trans-cyclopentane-1,2-diamines |
| 01/21/2010 | WO2010006725A1 Insecticidal compounds |
| 01/21/2010 | WO2009130735A4 Fatty acid derivatives for oral administration endowed with high paia- tability |
| 01/21/2010 | US20100016589 Novel Anthranilic Acid Derivative as Potential Anticancer Agent and a Process for the Preparation Thereof |
| 01/21/2010 | US20100016374 Compounds Which Inhibit the Glycine Transporter and Uses Thereof |
| 01/21/2010 | US20100016291 Mtp inhibiting tetrahydro-naphthalene-1-carboxylic acid derivatives |
| 01/21/2010 | US20100016259 Malonyl-CoA Decarboxylase Inhibitors Useful as Metabolic Modulators |
| 01/21/2010 | US20100016252 Mannich Base N-Oxide Drugs |
| 01/21/2010 | US20100015076 Polymer structure reacting with keratin, synthesis and use thereof |
| 01/21/2010 | CA2728915A1 Benzyloxy anilide derivatives useful as potassium channel modulators |
| 01/20/2010 | EP2145873A1 New compounds with activity that protects against the action of toxins and viruses in intracellular action mode |
| 01/20/2010 | EP2144869A1 Improved process for working up diacetone acrylamide solutions for the preparation of pure diacetone acrylamide |
| 01/20/2010 | EP1654247B1 Alkynyl aryl carboxamides |